Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Swiss Med Wkly ; 147: w14511, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29063525

RESUMO

AIMS OF THE STUDY: Skin cancer is a burden to healthcare and patients worldwide. The incidence of skin cancer has been rising during recent decades and this trend is expected to continue in the future. Numerous risk factors have been identified and prevention strategies developed. The Euromelanoma campaign is a pan-European skin cancer prevention programme, targeted to both primary and secondary prevention of malignant melanoma. The current study aimed to evaluate the results of the Swiss skin cancer screening day 2016. METHODS: A questionnaire was used to obtain data on characteristics and suspected skin cancers of all participants. Follow-up of patients with suspicious lesions was performed 3 to 6 months later. RESULTS: During the campaign, 2795 people were screened. Of the screened individuals, 157 participants (58% female, 42% male; mean age 58.8 years) underwent further evaluations; 6 cutaneous malignant melanomas, 21 basal cell carcinomas and 2 squamous cell carcinomas were detected. Detection rates were 0.21% for cutaneous melanoma, 0.75% for basal cell carcinoma and 0.07% for squamous cell carcinoma. CONCLUSIONS: Our study provides an up-to-date evaluation of the Swiss Euromelanoma campaign 2016. The results are mostly in line with data from other European studies. Considering the morbidity, mortality and financial and social impact of skin cancer, the capacity to raise awareness of risk factors, skin cancer prevention methods and educating high-risk and at-risk individuals, we may assume that a National Screening Day has a crucial impact on the public health system.


Assuntos
Detecção Precoce de Câncer/tendências , Promoção da Saúde/tendências , Programas de Rastreamento , Neoplasias Cutâneas/epidemiologia , Idoso , Carcinoma/diagnóstico , Detecção Precoce de Câncer/métodos , Feminino , Promoção da Saúde/organização & administração , Humanos , Incidência , Masculino , Melanoma/diagnóstico , Pessoa de Meia-Idade , Fatores de Risco , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/prevenção & controle , Inquéritos e Questionários , Suíça/epidemiologia
2.
J Dermatol Sci ; 54(2): 99-105, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19264456

RESUMO

BACKGROUND: Psoriasis is a chronic immune-mediated skin disease, in which interleukins 12 and 23 have been postulated to play a critical role. However, the cellular source of these cytokines in psoriatic lesions are still poorly defined and their relative contribution in inducing skin inflammation has been discussed controversially. OBJECTIVES: To investigate immunoreactivity of the bioactive forms of IL-12 and IL-23 in plaque psoriasis and to characterize the dendritic cell (DC) and macrophage subsets responsible for the production of these cytokines. METHODS: Immunohistochemistry was performed on normal skin (n=11) as well as non-lesional (n=11) and lesional (n=11) skin of patients with plaque psoriasis using monoclonal antibodies targeting the bioactive forms of IL-12 (IL-12p70) and IL-23 (IL-23p19/p40) on serial cryostat sections using the alkaline phosphatase-antialkaline phosphatase. Co-localization of IL-12 and IL-23 with different dendritic cells and macrophage cell markers (CD1a, CD11c, CD14, CD32, CD68, CD163, CD208/DC-LAMP) was performed using double immunofluorescence staining. RESULTS: Immunoreactivity for IL-12 and IL-23 was significantly enhanced in lesional psoriatic skin as compared to non-lesional and normal skin. No difference was observed between IL-12 and IL-23 immunoreactivity in any skin types. Both IL-12 and IL-23 immunoreactivity was readily detected mainly in CD11c+, CD14+, CD32+, CD68+ and some CD163+, DC-LAMP+ cells. IL-12 and occasionally IL-23 were also found in some CD1a+ dendritic cells. In addition, an enhanced expression mainly of IL-23 was observed in keratinocytes. CONCLUSIONS: Bioactive forms of IL-12 and IL-23 are highly expressed in various DC and macrophage subsets and their marked in situ production suggest that both cytokines have crucial pathogenic role in psoriasis.


Assuntos
Células Dendríticas/imunologia , Interleucina-12/biossíntese , Subunidade p19 da Interleucina-23/biossíntese , Macrófagos/imunologia , Psoríase/imunologia , Pele/imunologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Células Dendríticas/citologia , Feminino , Humanos , Queratinócitos/imunologia , Macrófagos/citologia , Masculino , Pessoa de Meia-Idade , Psoríase/patologia , Pele/patologia
3.
J Dtsch Dermatol Ges ; 4(2): 141-2, 2006 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-16503942

RESUMO

Treatment of pyogenic granuloma may be difficult in locations such as the face and fingertips. We successfully treated a 1 cm periungual fingertip pyogenic granuloma with a dye laser.


Assuntos
Dedos , Granuloma Piogênico/radioterapia , Terapia com Luz de Baixa Intensidade , Doenças da Unha/radioterapia , Adulto , Seguimentos , Humanos , Masculino
4.
Eur J Dermatol ; 16(1): 79-83, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16436349

RESUMO

Mycobacterium marinum can cause fish tank granuloma (or swimming pool or aquarium granuloma) in immunocompetent patients. Dissemination of Mycobacterium marinum-infection is a rare condition which occurs mainly in immunocompromised patients and can be life-threatening. We report the case of an 87-year-old woman who was treated with oral corticosteroids for polymyalgia rheumatica for many years and developed erythema nodosum-like lesions on the right forearm and arthritis of the right wrist. By increasing the steroid dosage and adding methotrexate only short-term remission was achieved. Seven months later painful erythematous nodules occurred on all extremities which became necrotic, ulcerative and suppurative. Ziehl-Neelsen staining revealed acid-fast bacilli and Mycobacterium marinum was cultured from skin biopsies, blood, and urine. The critically ill patient was treated with clarithromycin and ethambutol resulting in a dramatic improvement of the general condition. After four months, doxycycline had to be added because of new skin lesions. This case illustrates the impact of Mycobacterium marinum infection in immunocompromised patients.


Assuntos
Bacteriemia/tratamento farmacológico , Bacteriemia/microbiologia , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Mycobacterium marinum/isolamento & purificação , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/uso terapêutico , Antituberculosos/uso terapêutico , Bacteriemia/fisiopatologia , Estado Terminal , Quimioterapia Combinada , Feminino , Seguimentos , Humanos , Hospedeiro Imunocomprometido , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Infecções por Mycobacterium não Tuberculosas/imunologia , Polimialgia Reumática/diagnóstico , Polimialgia Reumática/tratamento farmacológico , Polimialgia Reumática/imunologia , Medição de Risco , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...